Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of LCZ696 Compared to Ramipril in Post-AMI Patients With LV Dysfunction
CTR20170798Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in myocardial infarction (MI), left ventricular dysfunction, sponsored by Novartis. Started Jul 2017; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
myocardial infarction (MI)left ventricular dysfunction
Beyond the preview
Go deeper on CTR20170798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170798.